14 reports

Abstract: - Global Molecular Cytogenetics Market to Reach $3.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Molecular Cytogenetics estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$3.1 Billion by 2027, growing at a CAGR of 8.2% over the analysis period 2020-2027....

  • Cytogenetic
  • World
  • China
  • United States

Molecular Cytogenetics Market Report Overview Molecular Cytogenetics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Molecular Cytogenetics market types and applications. It is a focused study on Molecular Cytogenetics market space...

  • Cytogenetic
  • World
  • Health Provider Density

The global molecular cytogenetics market grew at a CAGR of around 12% during 2014-2019. Molecular cytogenetics refers to the biomedical research of deoxyribonucleic acid (DNA) mechanisms to investigate genetic mutations and disorders. It studies the structural and functional organization of the chromosomes and their...

  • Cytogenetic
  • World

Cytogenetics Market by Product (Consumables, Instruments, and Software & Services), Technique (Comparative Genomic Hybridization, Fluorescence in Situ Hybridization (FISH), Karyotyping, Immunohistochemistry, and Others), Application (Genetic Disorders, Cancer, Personalized Medicine, and Others), and End User (Clinical & Research Laboratories,...

  • Cytogenetic
  • Genetic Disorder
  • World
  • Chronic Disease Prevalence

##.## Diagnosed Incident Cases of CLL by High-Risk Cytogenetics

  • Leukemia
  • Epidemiology
  • Cytogenetic
  • World
  • Elderly Population
  • Prescription Drug Sales

Global molecular cytogenetics market is forecasted to attain revenue of $3.3 billion by 2023, The market is mainly driven by growing implementation of pharmacogenomics in personalized disease management and drug development, rising cancer cases, advancements in cytogenetic techniques, and rise in genetic-based prediction of chromosomal...

  • Cytogenetic
  • World
  • APAC
  • Health Expenditure

The global fluorescence in situ hybridization (FISH) probe market grew at a CAGR of around 7% during 2014-2019. Fluorescence in situ hybridization (FISH) refers to a sub-atomic cytogenetic technique that uses fluorescent probes to visualize genetic materials. These probes are molecules that absorb light of a specific...

  • Cytogenetic
  • World

This study covers the world outlook for molecular cytogenetics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Cytogenetic
  • World
  • Gross Domestic Product
  • Disposable Income

In Situ Hybridization (ISH) Market Size, Share & Trends Analysis Report By Technology (FISH, CISH), By Type (DNA, RNA) By Product (Instruments, Probes & Kits), By Application, By End Use, And Segment Forecasts, 2018 - 2025 The global in situ hybridization (ISH) market size is expected to reach USD 1.84 billion by 2025, according to...

  • Diagnostics
  • Clinical Research
  • Drug Development
  • Molecular Diagnostics
  • Cancer Diagnostics
  • Cytogenetic
  • Infectious Disease
  • Fuels
  • Genetic Disorder
  • Laboratory
  • Molecular Biology
  • World
  • APAC
  • North America
  • Fuel Demand

## MOLECULAR CYTOGENETICS MARKET, BY REGION

  • Cytogenetic
  • United States
  • World
  • Europe
  • India
  • North America
  • Asia
  • Cancer Incidence
  • Health Expenditure

Summary NeoGenomics Inc (NeoGenomics) is a specialized oncology reference laboratory that provides biopharma and other testing technologies for anatomic pathology and oncology markets. It offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry,...

  • Pharmaceutical
  • Drug Development
  • Cytogenetic
  • Biopharmaceutical
  • Healthcare
  • Genome Sequencing
  • Clinical Trial
  • Biomarker
  • APAC
  • Europe
  • Lee County
  • North America
  • Middle East
  • Africa

Summary Empire Genomics LLC (Genomics) is a medical device company that offers molecular diagnostic solutions. The company offers ID labs products, fish probes, BAC clones, genotyping and circulating tumor cell products. Its services comprise array CGH, gene expression, clinical and custom services. Genomics’s ID lab products...

  • Genomics
  • Cytogenetic
  • APAC
  • Europe
  • North America
  • Middle East
  • Africa
  • Erie County

Summary MetaSystems GmbH (MetaSystems) is a medical device company that offers automated scanning and image analysis. The company’s product segments include slide scanning, karyotyping and fluorescence imaging; and DNA probe kits. Its slide scanning with Metafer and its software modules offer tools for automated analysis and...

  • Medical Equipment
  • Cytogenetic
  • Medical Device
  • APAC
  • Europe
  • North America
  • Middle East
  • Africa

CombiMatrix Corporation United States California Molecular Diagnostics Clinical Diagnostic Cytogenetic Genetic Testing Financial Services Diagnostics

  • Molecular Diagnostics
  • Financial Services
  • Private Placement
  • Cytogenetic
  • Research Center
  • Defense
  • Genomics
  • United States
  • World
  • Dates Price